Expanded population of CD1d-restricted Va24+ cells in a patient with active rheumatoid arthritis. (2014)

First Author: Gutowska-Owsiak D
Attributed to:  RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.clim.2013.11.006

PubMed Identifier: 24412906

Publication URI: http://europepmc.org/abstract/MED/24412906

Type: Journal Article/Review

Volume: 150

Parent Publication: Clinical immunology (Orlando, Fla.)

Issue: 2

ISSN: 1521-6616